Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,479 across all filing types
Latest filing 2026-04-23 Earnings Release
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Coloplast A/S - Coloplast revises financial guidance for FY 2025/26 to reflect reduced growth outlook for Kerecis
Earnings Release Classification · 1% confidence The document is a company announcement providing key financial highlights for Q2 and H1 of FY 2025/26, including organic growth, EBIT figures, and revisions to full-year guidance, along with details on an upcoming analyst teleconference. It is not the full half-year report (which is scheduled for release later) nor a detailed Excel supplement or governance filing. It is an initial earnings update—an earnings release summarizing period results and revised outlook. Therefore, it fits the Earnings Release category (ER). Q2 2026
2026-04-23 Danish
Coloplast A/S - Coloplast revises financial guidance for FY 2025/26 to reflect reduced growth outlook for Kerecis
Earnings Release Classification · 1% confidence The document is a company announcement labeled “Selskabsmeddelelse nr. 04/2026” providing interim financial highlights for Q2 and H1 of FY 2025/26 along with a full-year guidance revision and arrangements for an extraordinary teleconference. It is not a full interim report (which is scheduled for 12 May) but a preliminary trading update and financial results release. This fits the definition of an Earnings Release (initial announcement of periodical financial results and guidance). Q2 2026
2026-04-23 Danish
Coloplast A/S - Coloplast revises financial guidance for FY 2025/26 to reflect reduced growth outlook for Kerecis
Earnings Release Classification · 1% confidence The document is an “inside information” press release containing key Q2 and H1 financial highlights and a mid‐year guidance revision. It is not the full interim report (which is due May 12), nor a transcript or detailed annual filing. It matches the profile of an Earnings Release announcing periodical financial results and guidance updates. H1 2026
2026-04-23 English
Coloplast A/S - Coloplast revises financial guidance for FY 2025/26 to reflect reduced growth outlook for Kerecis
Earnings Release Classification · 1% confidence The document is an investor announcement providing key Q2 and H1 financial highlights and, crucially, a revision of full-year guidance for FY 2025/26. It is structured as a summary earnings update rather than a full interim report (which is scheduled for May 12), matching the definition of an Earnings Release (initial announcement of quarterly/periodical financial results and guidance). It is not a full Interim Report, not a financing or capital structure update, and not simply a report publication notice. H1 2026
2026-04-23 English
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document is a formal notification of a transaction in company shares by a member of the executive management (CFO Anders Lonning-Skovgaard). It explicitly references the Market Abuse Regulation (Markedsmisbrugsforordningen) Article 19, which governs the reporting of insider dealings. This fits the definition of a 'Director's Dealing' (DIRS) filing.
2026-03-12 Danish
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document title 'Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier' translates to 'Transactions in Coloplast shares by board members, directors, or closely related persons'. This is a standard notification for insider trading or director dealings. Since the document is short and directs the reader to an attached PDF for the specific transaction details, it fits the definition of a Director's Dealing report.
2026-03-12 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.